Medical-device intelligence
Abbott: selected FDA company records
Connect selected Abbott source names with their classification, clearance, and recall histories.
Included source names
Membership is based on Abbott Laboratories, 2025 Form 10-K, Exhibit 21 ↗, as of Jan 31, 2026. Mapping checked Nov 19, 2026. This is a selected research group, not a complete corporate family or a statement of current ownership.
- Abbott Laboratories
- Abbott Diabetes Care Inc.
- Abbott Point of Care Inc.
- Abbott Cardiovascular Systems Inc.
- Abbott Molecular Inc.
- Abbott Vascular Inc.
Matching FDA profiles
- Abbott Laboratories · 1,058 records
- Abbott Diabetes Care, Inc. · 94 records
- Abbott Point of Care Inc. · 98 records
- Abbott Molecular, Inc. · 46 records
- Abbott Vascular Inc · 26 records
Record activity in this scope
978 clearance records and 344 recall records in the covered releases, across 5 source company names and 318 product codes. Dated history runs from Sep 16, 1976 to Sep 23, 2026.
Monthly counts through October 2026
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 5 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 1 | 3 |
| May 2026 | 0 | 0 |
| June 2026 | 2 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 1 | 0 |
| October 2026 | 0 | 0 |
Product codes represented
Clearances and recall records
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| Abbott Alinity m System, REF 08N53-002, containing Amplification Detetction Unit (ADU) #4.Z-1349-2023 · OOI | Abbott Molecular, Inc. | Recall | Apr 6, 2023FDA classification date |
| Alinity m STI AssayK222379 · QEP | Abbott Molecular, Inc. | 510(k) | Mar 3, 2023FDA decision date |
| FreeStyle Libre 2 Flash Glucose Monitoring System; Freestyle Libre 3 Continuous Glucose Monitoring SystemK222447 · QBJ | Abbott Diabetes Care, Inc. | 510(k) | Mar 3, 2023FDA decision date |
| Traumatic brain injury (TBI) testK223602 · QAT | Abbott Laboratories | 510(k) | Mar 2, 2023FDA decision date |
| FreeStyle Libre 2 System, FreeStyle Libre 3 SystemK223537 · QLG | Abbott Diabetes Care, Inc. | 510(k) | Feb 21, 2023FDA decision date |
| Alinity m System. The Alinity m System is designed to automate the steps for nucleic acid testing, which includes sample processing, amplifica…Z-1009-2023 · OOI | Abbott Molecular, Inc. | Recall | Jan 20, 2023FDA classification date |
| Alinity Reaction Vessels, REF: 06P1401, for use with Alinity i Systems; ARCHITECT Reaction VesselsZ-0958-2023 · DHA | Abbott Laboratories | Recall | Jan 17, 2023FDA classification date |
| Abbott Alinity m Resp-4-Plex Amp Kit, Part Number 09N79-096Z-0739-2023 · QJR | Abbott Molecular, Inc. | Recall | Dec 20, 2022FDA classification date |
| Abbott Alinity m Resp-4-Plex Amp Kit, Part Number 09N79-090Z-0740-2023 · QJR | Abbott Molecular, Inc. | Recall | Dec 20, 2022FDA classification date |
| Alinity m System, REF 08N53-002, For In Vitro Diagnostic UseZ-0268-2023 · OOI | Abbott Molecular, Inc. | Recall | Nov 18, 2022FDA classification date |
| Architect CMV IgGK220949 · LFZ | Abbott Laboratories | 510(k) | Oct 27, 2022FDA decision date |
| Abbott Alinity m SARS-CoV-2 CTRL Kit, REF 09N78-085, each kit contains 12 x 1.3mL CTRL - and 12 x 1.3 mL CTRL +, For In Vitro Diagnostic Use.Z-1679-2022 · QJR | Abbott Molecular, Inc. | Recall | Sep 6, 2022FDA record creation date |
| ARCHITECT STAT Troponin-I Reagent Kit, REF 2K41-27Z-1660-2022 · MMI | Abbott Laboratories | Recall | Aug 30, 2022FDA record creation date |
| The Alinity m System, REF 08N53-002, For In Vitro Diagnostic Use.Z-1518-2022 · MZP | Abbott Molecular, Inc. | Recall | Aug 12, 2022FDA record creation date |
| REF: 4P52-20 Hemoglobin A1c for use with Architect, IVD, CE, R1 1 x 52 mL, R2 1 x 20 mL, A1cDL 2 x 35 mLZ-1454-2022 · PDJ | Abbott Laboratories | Recall | Jul 22, 2022FDA record creation date |
| REF: 08P4320, Alinity c Hemoglobin Reagent Kit, IVD, CE, R1 5 x 46.0 mL, R2 5 x 18.3 mL, A1cDL 5 x 67.6 mLZ-1455-2022 · PDJ | Abbott Laboratories | Recall | Jul 22, 2022FDA record creation date |
| REF: 08P4377, Alinity c Hemoglobin Reagent Kit, IVD, CE, R1 5 x 46.0 mL, R2 5 x 18.3 mL, A1cDL 5 x 67.6 mLZ-1456-2022 · PDJ | Abbott Laboratories | Recall | Jul 22, 2022FDA record creation date |
| Alinity m EBV AMP Kit (List No. 09N43-095), Alinity m EBV CTRL Kit (List No. 09N43-085), Alinity m EBV CAL Kit (List No. 09N43-075)K212778 · QLX | Abbott Molecular, Inc. | 510(k) | Jul 15, 2022FDA decision date |
| FreeStyle Libre 3 Continuous Glucose Monitoring SystemK212132 · QLG | Abbott Diabetes Care, Inc. | 510(k) | May 26, 2022FDA decision date |
| FreeStyle Libre 3 Continuous Glucose Monitoring SystemK213996 · QLG | Abbott Diabetes Care, Inc. | 510(k) | May 26, 2022FDA decision date |
| ARCHITECT Toxo IgGK210596 · LGD | Abbott Laboratories | 510(k) | May 19, 2022FDA decision date |
| Alinity m STI AssayK202977 · QEP | Abbott Molecular, Inc. | 510(k) | Apr 29, 2022FDA decision date |
| ARCHITECT STAT Myoglobin Calibrators, RES 2K43-01 The ARCHITECT STAT Myoglobin Calibrators are for the calibration of the ARCHITECT iSystem with…Z-0891-2022 · JIS | Abbott Laboratories | Recall | Apr 7, 2022FDA record creation date |
| Alinity m HBV Application Specification File (US and CE)Z-0883-2022 · MKT | Abbott Molecular, Inc. | Recall | Apr 6, 2022FDA classification date |
| Alinity m HBV AMP Kit (US and CE)Z-0884-2022 · MKT | Abbott Molecular, Inc. | Recall | Apr 6, 2022FDA classification date |
FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Keep this research moving.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.